Fund HoldingsLion Point Capital, LP

Total Portfolio Value
$15.68M
Total Bought
$518.4K
Total Sold
$2.40M
Net Transaction
-$1.88M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
MINERALYS THERAPEUTICS INC(MLYS)79,00079,00009721,2558.00%+282
MERSANA THERAPEUTICS INC0644,000+644,00002221.41%+222
HUMACYTE INC083,500+83,50001420.91%+142
KINIKSA PHARMACEUTICALS LTD(KNSA)45,90045,90009081,0196.50%+112
AVADEL PHARMACEUTICALS PLC64,00098,700+34,7006737734.93%+100
ARCUTIS BIOTHERAPEUTICS INC(ARQT)46,30046,30006457244.62%+79
BENITEC BIOPHARMA INC62,00062,00007838075.15%+24
SPRUCE BIOSCIENCES INC75,00075,000032220.14%-10
REGENXBIO INC57,75057,75004464132.63%-33
SERES THERAPEUTICS INC340,761340,76102832391.52%-45
FENNEC PHARMACEUTICALS INC195,700195,70001,2371,1927.60%-45
SYNDAX PHARMACEUTICALS INC(SNDX)55,00055,00007276764.31%-51
ARDELYX INC335,400335,40001,7001,64710.51%-54
JASPER THERAPEUTICS INC32,000146,500+114,5006846304.02%-54
DISC MEDICINE INC(IRON)10,60010,60006725263.36%-146
INSMED INC(INSM)36,70030,500-6,2002,5342,32714.84%-207
BRIDGEBIO PHARMA INC(BBIO)40,30026,000-14,3001,1068995.73%-207
BLUEBIRD BIO INC78,91278,91206583852.46%-273
BIOHAVEN LTD(BHVN)22,70022,70008485463.48%-302
GERON CORP(GERN)500,000500,00001,7707955.07%-975
MILESTONE PHARMACEUTICALS IN1,025,806548,806-477,0002,4214392.80%-1,982
Page 1 of 1